Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
9.61
+0.45 (4.91%)
Jul 25, 2025, 4:00 PM - Market closed
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
$580,919
Profits / Employee
$95,400
Market Cap
2.99B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALVO News
- 16 days ago - Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer - GlobeNewsWire
- 17 days ago - Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland - GlobeNewsWire
- 17 days ago - Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland - GlobeNewsWire
- 23 days ago - Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers - GlobeNewsWire
- 24 days ago - Granting of Stock Options and Vesting of Restricted Share Units - GlobeNewsWire
- 25 days ago - Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) - GlobeNewsWire
- 4 weeks ago - Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility - GlobeNewsWire
- 4 weeks ago - Main Results of 2025 Annual and Extraordinary General Meeting - GlobeNewsWire